Inventor · disambiguated record
Koichiro Yoneyama
Also filed as: YONEYAMA KOICHIRO
1 granted patent·17 pending applications·4 citations·filing 2015–2024
28Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD18
Top patents by PatentIndex Score
18 records- 0176US11352438B2Methods of using a bispecific antibody that recognizes coagulation factor IX and/or activated coagulation factor IX and coagulation factor X and/or activated coagulation factor XCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Granted Jun 7, 2022·4 cites·13 claims
- 0276US2024317891A1Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0374US2024052060A1Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0473US2024052058A1Methods of using a bispecific antibody that recognizes coagulation factor ix and/or activated coagulation factor ix and coagulation factor x and/or activated coagulation factor xCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0571US2023174673A1Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0670US2023159658A1Methods of using a bispecific antibody that recognizes coagulation factor ix and/or activated coagulation factor ix and coagulation factor x and/or activated coagulation factor xCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0769US2022324999A1Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0868US2023250162A1Pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related diseaseCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0967US2022315667A1Methods of using a bispecific antibody that recognizes coagulation factor ix and/or activated coagulation factor ix and coagulation factor x and/or activated coagulation factor xCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1066US2022073645A1Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1163US2021238307A1Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1261US2020407463A1Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1359US2020157243A1Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1459US2019309090A1Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1556US2020407432A1Pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related diseaseCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1651US2017253663A1Methods for treating a disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Application pending·0 cites
- 1746US2019367599A1Pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related diseaseCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 1839US2022305122A1Pharmaceutical composition which can be used for prevention and/or treatment of acquired hemophilia a, and product comprising said pharmaceutical compositionCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Koichiro Yoneyama files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →